Carregant...
Denosumab-induced hypocalcaemia in metastatic castrate-resistant prostate cancer
SUMMARY: Denosumab is a fully human MAB that acts as a potent anti-resorptive by inhibiting activation of osteoclasts by inhibiting the receptor activator of nuclear factor-kappa B (RANK) ligand. Hypocalcaemia has been reported as one of the serious adverse sequelae of use of denosumab. We present a...
Guardat en:
| Publicat a: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Bioscientifica Ltd
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6935716/ https://ncbi.nlm.nih.gov/pubmed/31829971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-19-0063 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|